- Detrusor Overactivity May Be a Prognostic Factor for Better Response to Combination Therapy Over Monotherapy in Male Patients With Benign Prostatic Enlargement and Storage Lower Urinary Tract Symptoms
-
Sakalis V, Sfiggas V, Vouros I, Salpiggidis G, Papathanasiou A, Apostolidis A
- KMID: 2514217
- Int Neurourol J.
- 2021 Mar;25(1):69-76.
- doi: 10.5213/inj.2040188.094
Purpose: Several trials have shown that in men with overactive bladder (OAB) and benign prostate enlargement (BPE), the combination of an α-blocker with an anticholinergic is superior to α-blocker monotherapy.... -
- CITED
-
- Close
- SHARE
-
- Close
